SANUWAVE Health, Inc. (SNWV), our long term holding, has received a patent issued by the U.S. Patent and Trademark Office entitled “Extracorporeal Shock Wave Device.” The claims of the patent (patent number 8,556,813) relate to a new extracorporeal applicator, which creates significant advantages for certain applications. The patent has a term extending to April 2031.
Joseph Chiarelli, Chief Executive Officer of SANUWAVE, commented:
“This new patent adds to our intellectual property portfolio. This new type of applicator can be used for cardiology, endovascular, as well as other applications. Our strategy is to maximize the value of SANUWAVE’s shock wave technology – to expand the technology’s use into as many applications as possible via this new applicator design.”
SANUWAVE focused on the development and commercialization of patented noninvasive, biological response activating devices for the repair and regeneration of skin, musculoskeletal tissue and vascular structures.
SANUWAVE’s portfolio of regenerative medicine products and product candidates activate biologic signaling and angiogenic responses, producing new vascularization and microcirculatory improvement, which helps restore the body’s normal healing processes and regeneration.
SANUWAVE applies its patented PACE technology in wound healing, orthopedic/spine, plastic/cosmetic and cardiac conditions.
Its lead product candidate for the global wound care market, dermaPACE(R), is CE Marked throughout Europe and has device license approval for the treatment of the skin and subcutaneous soft tissue in Canada, Australia and New Zealand.
An affiliate of PennyStockHaven.com received fifteen thousand dollars per month for providing consulting and advisory services to Sanuwave in the past and may receive up to twenty thousand dollars per month in the future. The affiliate may also receive up to four hundred thousand restricted shares in the company in the future. This compensation may affect the objectivity of our profile of the company. PennyStockHaven.com and/or its affiliates own shares acquired in a private placement and may sell these shares at any time. You should do your own homework and consult an investment professional before making any investment decisions. Read our full disclaimer here.